Immunostaining using antibodies against smooth muscle actin (α-SMA) was present in 3 MGTs interpreted to be complex carcinomas and in 1 neoplasm that was classified as a malignant myoepithelioma. This evidence concerns the gene ACTA1 and carcinoma.